Scientists have discovered that a molecule called kalata B1, found in violets, can significantly enhance the effectiveness of the chemotherapy drug Temozolomide (TMZ) in treating glioblastoma. This synthetic molecule reduced the amount of TMZ required to kill cancer cells by over tenfold in lab tests. Researchers believe that the synthetic version of kalata B1, which mirrors the natural molecule’s structure, could be a potential breakthrough in glioblastoma treatment. While the discovery is promising, the team stresses that clinical trials are still far off.
